Organization
The First Affiliated Hospital of Xi'an Jiaotong University
1 abstract
Abstract
Adjuvant or rescue disitamab vedotin (RC48-ADC) for high-risk non-muscle invasive bladder cancer with HER2 overexpression: A phase II multi-center study.Org: The First Affiliated Hospital of Xi'an Jiaotong University,